WallStreetZenWallStreetZen

NYSEMKT: VNRX
Volitionrx Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VNRX past revenue growth

How has VNRX's revenue growth performed historically?
Company
153.04%
Industry
0.14%
Market
16.96%
VNRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VNRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VNRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VNRX earnings and revenue history

Current Revenue
$775.3k
Current Earnings
-$35.3M
Current Profit Margin
-4,555.5%

VNRX Return on Equity

Current Company
N/A
Current Industry
-24%
Current Market
188%

Be the first to know when VNRX announces earnings.

VNRX Return on Assets

Current Company
-154.2%
Current Industry
6.7%
VNRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VNRX Return on Capital Employed

Current Company
903.04%
Current Industry
11.6%
VNRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VNRX vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VNRX$775.30k-$33.68M-$35.32M+159.50%N/A
PSNL$73.48M-$94.95M-$108.30M+14.23%N/A
PRE$21.74MN/A-$62.72M+18.68%N/A
ENZ$12.81M$33.74M$32.57M-32.08%+117.39%
ACRS$31.25M-$87.99M-$88.48M+38.41%N/A
View Top Diagnostic & Research Stocks

VNRX earnings dates

Next earnings date
May 8, 2024

Volitionrx Earnings & Revenue FAQ

What were VNRX's earnings last quarter?

On Invalid Date, Volitionrx (NYSEMKT: VNRX) reported Q4 2023 earnings per share (EPS) of -$0.11, up 15.38% year over year. Total Volitionrx earnings for the quarter were -$8.70 million. In the same quarter last year, Volitionrx's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Volitionrx stock.

What was VNRX's earnings growth in the past year?

As of Q2 2024, Volitionrx's earnings has grown year over year. Volitionrx's earnings in the past year totalled -$35.32 million.

What is VNRX's earnings date?

Volitionrx's earnings date is Invalid Date. Add VNRX to your watchlist to be reminded of VNRX's next earnings announcement.

What was VNRX's revenue last quarter?

On Invalid Date, Volitionrx (NYSEMKT: VNRX) reported Q4 2023 revenue of $243.97 thousand up 103.79% year over year. In the same quarter last year, Volitionrx's revenue was $119.72 thousand.

What was VNRX's revenue growth in the past year?

As of Q2 2024, Volitionrx's revenue has grown 153.04% year over year. This is 152.9 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.14%. Volitionrx's revenue in the past year totalled $775.30 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.